Title
From Breakthrough To Blockbuster: The Business Of Biotechnology-new
Processing time: 1-3 days
US Orders Ships in: 3-5 days
International Orders Ships in: 8-12 days
Return Policy: 15-days return on defective items
Payment Option
Financial Times Business Top Title March 2022How Could A Large Collection Of Small Companies, Most With Fewer Than 50 Employees, Rise To Compete With Big Pharma, One Of The Worlds Most Breathtakingly Expensive And Highly Regulated Industries?Beginning In The 1970S, Several Scientific Breakthroughs Promised To Transform The Creation Of New Medicines. As Investors Sought To Capitalize On These Nobel Prizewinning Discoveries, The Biotech Industry Grew To Thousands Of Small Companies Around The World. Each Sought To Emulate What The Major Pharmaceutical Companies Had Been Doing For A Century Or More, But Without The Advantages Of Scale, Scope, Experience, And Massive Resources.Biotech Companies Have Met The Challenge By Creating Nearly 40% More Of The Most Important Treatments For Previously Unmet Medical Needs. Moreover, They Have Done So With Much Lower Overall Costs.From Breakthrough To Blockbuster: The Business Of Biotechnology Focuses On Both The Companies Themselves And The Broader Biotech Ecosystem That Supports Them. It Paints A Portrait Of The Crucial Roles Played By Academic Research, Venture Capital, Contract Research Organizations, The Capital Markets, And Pharmaceutical Companies, Demonstrating How A Supportive Environment Enabled The Entrepreneurial Biotech Industry To Create Novel Medicines With Unprecedented Efficiency. In Doing So, It Also Offers Insights For Any Industry Seeking To Innovate In Uncertain And Ambiguous Conditions.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: What is the page count of the book? A: The book has two hundred forty pages. This length allows for a comprehensive exploration of the biotechnology business landscape.
- Q: What are the dimensions of the book? A: The book measures six inches in length, one inch in width, and nine point zero two inches in height. These dimensions make it easy to handle and store.
- Q: What type of binding does the book have? A: The book is bound in hardcover. This binding adds durability and a professional appearance, making it suitable for both personal and classroom use.
- Q: Who is the author of this book? A: The author is Donald L. Drakeman. His expertise in biotechnology and business provides valuable insights throughout the book.
- Q: What is the primary subject matter of the book? A: The primary subject matter is the business of biotechnology. It covers the rise of biotech companies and their competition with large pharmaceutical firms.
- Q: What is the target audience for this book? A: The book targets professionals, students, and anyone interested in the biotechnology industry. It offers insights valuable for those in business, science, and healthcare.
- Q: How can I apply the insights from this book? A: You can apply the insights by understanding the business dynamics of biotechnology. This knowledge can be beneficial for making informed decisions in related fields.
- Q: Is this book suitable for beginners in biotechnology? A: Yes, the book is suitable for beginners. It provides a foundational understanding of biotechnology's business aspects without requiring prior expertise.
- Q: Can this book help with understanding venture capital in biotech? A: Yes, the book discusses venture capital's role in biotechnology. It highlights how funding influences innovation and company growth in the sector.
- Q: What should I do to keep this book in good condition? A: To keep the book in good condition, store it upright and avoid exposure to direct sunlight. Regularly dusting the cover will also maintain its appearance.
- Q: Is there any specific way to clean the book? A: Yes, you can clean the book by gently wiping the cover with a soft, dry cloth. Avoid using water or cleaning solutions that may damage the material.
- Q: What if the book arrives damaged? A: If the book arrives damaged, you should contact the seller for a return or replacement. Most sellers have policies in place to address such issues.
- Q: Does this book provide real-world examples? A: Yes, the book includes real-world examples from the biotechnology industry. These examples illustrate the concepts discussed and enhance understanding.
- Q: Can I find case studies in this book? A: Yes, the book features case studies that demonstrate the success and challenges faced by biotech companies. These case studies provide practical insights.
- Q: Is there a glossary of terms in the book? A: No, the book does not specifically include a glossary. However, it explains terms within the context, aiding reader comprehension.
- Q: Is this book recommended for academic use? A: Yes, the book is recommended for academic use. Its thorough analysis of biotechnology business practices makes it valuable for coursework and research.